XT Venture Capital

Venture Capital Active Tel Aviv-Yafo, Israel Est. 1997
Last updated 2026-06-18
Portfolio
20
in our dataset
Rounds participated
25
Rounds led
4
Rounds' value
$401.2M
total disclosed, rounds participated
Stages
B Round, Seed, A Round

About

XT is among the early investors in Israeli startups. Focusing on early-growth companies with the potential to become market frontrunners, XT leverages its strong, experienced team to drive success. To date, XT has invested in 100 companies, resulting in exits and category leaders such as Duve, Checkmarx, Lumenis, Enzymotec, Cymbio, Sofwave, and Phytech.

Portfolio · 20

Orion Security
Detects and Prevents Data Exfiltration by Understanding Organizational Business Flows
1 round $32.0M committed Latest: 2026-02
Duve
AI-powered Guest Experience Platform
2 rounds $70.0M committed Latest: 2025-12
Localbird
Digital Concierge for Short-term Rentals
1 round $7.4M committed Latest: 2025-11
Dream Security
AI-powered cybersecurity for nations and critical infrastructure.
1 round $100.0M committed Latest: 2025-02
enSights
AI-Powered Renewable Energy Management Solutions
Led ★ 1 round $10.0M committed Latest: 2024-12
NeuReality
Transforming AI Inference with Disruptive NR1 Technology
2 rounds $55.0M committed Latest: 2024-03
Cymbio
Brand-to-Retail Connectivity
2 rounds $20.0M committed Latest: 2021-11
Beyeonics
Surgical Visualization Technologies
1 round Latest: 2021-10
BioT
Effortless Compliance for Health Tech AI Applications
1 round $6.9M committed Latest: 2021-06
Avenews
Financial Management Platform for Agribusiness
1 round $3.0M committed Latest: 2021-01
Sofwave Medical
The Regenerative Aesthetics Company
Led ★ 1 round $8.4M committed Latest: 2019-08
Epitomee Medical
Drug-free Capsules for Diabetes Prevention and Weight Loss
Led ★ 1 round $8.0M committed Latest: 2019-04
PainReform
Pain Treatment Drugs
1 round $12.0M committed Latest: 2017-12
Everysight
Smartglasses for Cyclists
1 round $5.0M committed Latest: 2014-10
Checkmarx
Cloud-Native AppSec Platform
1 round $6.5M committed Latest: 2011-10
Intratech Medical
Balloon Catheter Therapy for Treatment of Acute Myocardial Infarction
Led ★ 1 round Latest: 2007-12
Quiksee
Online Tour Technology
2 rounds $3.5M committed Latest: 2007-05
Chiasma
Oral Therapeutic Options for Patients with Rare Diseases
2 rounds $51.7M committed Latest: 2006-11
Como
End-to-end Customer Engagement Tools
1 round $1.8M committed Latest: 2006-07
Applied Spectral Imaging
Automated Imaging Platforms for Pathological Analysis
1 round Latest: 1998-01

Investment activity

7 portfolio exits on record.

Portfolio by sector

Health Tech & Life Sciences8
Cyber Security3
Business Software3
Media & Entertainment Technologies3
Fintech & Insurtech1
Retail Platforms1
Energy Tech1

Q&A

What is XT Venture Capital's most recent exit?
XT Venture Capital's most recent exit was Cymbio, which was acquired by PayPal in January 2026. Another recent exit was Applied Spectral Imaging, acquired by ZYTOMICS in August 2025.
What are some of XT Venture Capital's recent investments?
XT Venture Capital recently invested in Orion Security, participating in their A Round in December 2024. They also invested in Localbird, which raised a Seed round in February 2025.
Which sectors does XT Venture Capital primarily focus on for investments?
XT Venture Capital shows a strong focus on Health Tech & Life Sciences, with 8 portfolio companies in this sector. They also have significant investments in Cyber Security and Business Software, each with 3 portfolio companies.
Can you name some of XT Venture Capital's notable portfolio companies?
XT Venture Capital's portfolio includes Beyeonics, a surgical visualization technology company that raised a $47.5M Series B, and NeuReality, which secured a $63M Series A for AI inference technology.
What is the typical investment stage for XT Venture Capital?
XT Venture Capital primarily invests in Seed, A Round, and B Round stages. According to startupim data, they have made 8 A Round investments and 3 Seed investments.
What was XT Venture Capital's largest exit by disclosed amount?
XT Venture Capital's largest exit by disclosed amount was Checkmarx, which was acquired for $1.15 billion in March 2020 by Hellman & Friedman.
Who are the managing directors at XT Venture Capital?
The managing directors at XT Venture Capital are Yoav Sebba and Assif Stoffman.
Where is XT Venture Capital headquartered?
XT Venture Capital is headquartered in Tel Aviv-Yafo, Israel.
Full data — links, identifiers, deals & radar signals (jobs, patents, research, more)